Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.50 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.50 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 2/20 | 0.39 |
| ▸ | NPY4R | P50391 | 7/20 | 0.38 |
| ▸ | NPY1R | P25929 | 4/20 | 0.38 |
| ▸ | NPY2R | P49146 | 3/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.38 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.38 |
| ▸ | RAMP3 | O60896 | 5/20 | 0.37 |
| ▸ | CALCR | P30988 | 5/20 | 0.37 |
| ▸ | F11 | P03951 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29437943 | 0.90 | MAPK8 (0.43) | MAPK8MAPK9MAPK10KEAP1NPY4R | |
| SCHEMBL30242269 | 0.89 | MAPK8 (0.51) | MAPK8MAPK9MAPK10KEAP1KDM1A | |
| SCHEMBL30686002 | 0.87 | MAPK8 (0.42) | MAPK8MAPK9MAPK10KEAP1KDM1A | |
| SCHEMBL8720817 | 0.87 | MAPK8 (0.44) | MAPK8MAPK9MAPK10KEAP1KDM1A | |
| SCHEMBL8720811 | 0.87 | MAPK8 (0.44) | MAPK8MAPK9MAPK10KEAP1KDM1A | |
| SCHEMBL29663559 | 0.86 | MAPK8 (0.46) | MAPK8MAPK9MAPK10KEAP1NPY4R | |
| SCHEMBL29630744 | 0.85 | MAPK8 (0.50) | MAPK8MAPK9MAPK10KEAP1KDM1A | |
| SCHEMBL30686003 | 0.85 | MAPK8 (0.48) | MAPK8MAPK9MAPK10KEAP1CALCRL | |
| SCHEMBL30686004 | 0.85 | MAPK8 (0.48) | MAPK8MAPK9MAPK10KEAP1CALCRL | |
| SCHEMBL30171144 | 0.84 | KDM1A (0.48) | MAPK8MAPK9MAPK10KEAP1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381324-A1 | CD31 MIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2025-12-18 | — | — | US | disclosed |
| US-20250281679-A1 | BIOMIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2025-09-11 | — | — | US | disclosed |
| CN-118843485-A | Bionic coating of intravascular stent | 法国国家健康和医学研究院 | 2024-10-25 | — | — | CN | disclosed |
| EP-4440644-A2 | CD31 MIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2024-10-09 | — | — | EP | disclosed |
| EP-4440643-A2 | MEDICAL DEVICE WITH CD31 MIMETIC COATING | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2024-10-09 | — | — | EP | disclosed |
| CN-118475376-A | Medical instrument with CD31 bionic coating | 法国国家健康和医学研究院 | 2024-08-09 | — | — | CN | disclosed |
| WO-2023099932-A1 | CD31 MIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023099748-A2 | BIOMIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
| WO-2023099957-A2 | BIOMIMETIC COATING FOR ENDOVASCULAR STENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250381324-A1 | CD31 MIMETIC COATING FOR ENDOVASCULAR STENT | SELE, VCAM1, SELP | MAPK8 1789/4885MAPK9 819/4885MAPK10 1244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.